GR3033536T3 - 2,4- and 2,5-bis-(tetrazolyl)pyridines, process for their preparation and their use as medicines. - Google Patents
2,4- and 2,5-bis-(tetrazolyl)pyridines, process for their preparation and their use as medicines.Info
- Publication number
- GR3033536T3 GR3033536T3 GR20000401228T GR20000401228T GR3033536T3 GR 3033536 T3 GR3033536 T3 GR 3033536T3 GR 20000401228 T GR20000401228 T GR 20000401228T GR 20000401228 T GR20000401228 T GR 20000401228T GR 3033536 T3 GR3033536 T3 GR 3033536T3
- Authority
- GR
- Greece
- Prior art keywords
- pyridines
- tetrazolyl
- bis
- medicines
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4103372 | 1991-02-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3033536T3 true GR3033536T3 (en) | 2000-09-29 |
Family
ID=6424383
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR20000401228T GR3033536T3 (en) | 1991-02-05 | 2000-05-31 | 2,4- and 2,5-bis-(tetrazolyl)pyridines, process for their preparation and their use as medicines. |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US5482953A (el) |
| EP (1) | EP0498334B1 (el) |
| JP (1) | JPH0559041A (el) |
| KR (1) | KR100214797B1 (el) |
| AT (1) | ATE193288T1 (el) |
| AU (1) | AU650511B2 (el) |
| CA (1) | CA2060622A1 (el) |
| CZ (1) | CZ283006B6 (el) |
| DE (1) | DE59209838D1 (el) |
| DK (1) | DK0498334T3 (el) |
| ES (1) | ES2146581T3 (el) |
| FI (1) | FI103117B1 (el) |
| GR (1) | GR3033536T3 (el) |
| HR (1) | HRP940840B1 (el) |
| HU (1) | HUT61295A (el) |
| IE (1) | IE920368A1 (el) |
| IL (1) | IL100860A (el) |
| MX (1) | MX9200492A (el) |
| NO (1) | NO180446C (el) |
| NZ (1) | NZ241505A (el) |
| PT (1) | PT498334E (el) |
| YU (1) | YU9492A (el) |
| ZA (1) | ZA92788B (el) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ305460B6 (cs) * | 2013-05-06 | 2015-10-07 | Contipro Biotech S.R.O. | Způsob přípravy esteru 2-oxoglutarátu, přípravek obsahující ester 2-oxoglutarát a jeho použití |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3432094A1 (de) * | 1984-08-31 | 1986-03-06 | Hoechst Ag, 6230 Frankfurt | Ester der pyridin-2,4- und -2,5- dicarbonsaeure als arzneimittel zur inhibierung der prolin- und lysinhydroxylase |
| DE3703963A1 (de) * | 1987-02-10 | 1988-08-18 | Hoechst Ag | Pyridin-2,4- und 2,,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben, sowie arzneimittel auf basis dieser verbindungen |
| US5238948A (en) * | 1987-02-10 | 1993-08-24 | Hoechst Aktiengesellschaft | Pyridine-2,4- and -2,5-dicarboxylic acid derivatives and medicaments based on these compounds |
| DE3703959A1 (de) * | 1987-02-10 | 1988-08-18 | Hoechst Ag | Pyridin-2,4- und 2,5-dicarbonsaeureamide, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen |
| DE3703962A1 (de) * | 1987-02-10 | 1988-08-18 | Hoechst Ag | Pyridin-2,4- und 2,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen |
| EP0353668B1 (de) * | 1988-08-04 | 1994-10-19 | Hoechst Aktiengesellschaft | Verbessertes Verfahren zur Herstellung von N,N-Bis(alkoxyalkyl)-pyridin -2,4-dicarbonsäurediamiden |
| JPH02178263A (ja) * | 1988-12-27 | 1990-07-11 | Kaken Pharmaceut Co Ltd | アザアズレン誘導体、その製造法およびそれを有効成分とする抗アレルギー剤および抗炎症剤 |
| DE3924093A1 (de) * | 1989-07-20 | 1991-02-07 | Hoechst Ag | N,n'-bis(alkoxy-alkyl)-pyridin-2,4-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung |
| FR2655801B1 (fr) * | 1989-12-08 | 1992-03-13 | Charbonnages De France | Procede et dispositif de transmission de signaux video en milieu confine. |
| ZA91291B (en) * | 1990-01-16 | 1991-09-25 | Hoechst Ag | Di(nitroxyalkyl)amides of pyridine-2,4-and-2,5-dicarboxylic acids,a process for the preparation thereof,and the use thereof |
| DE4020570A1 (de) * | 1990-06-28 | 1992-01-02 | Hoechst Ag | 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung |
-
1992
- 1992-01-30 YU YU9492A patent/YU9492A/sh unknown
- 1992-02-01 KR KR1019920001589A patent/KR100214797B1/ko not_active IP Right Cessation
- 1992-02-03 PT PT92101709T patent/PT498334E/pt unknown
- 1992-02-03 AT AT92101709T patent/ATE193288T1/de not_active IP Right Cessation
- 1992-02-03 IL IL10086092A patent/IL100860A/en not_active IP Right Cessation
- 1992-02-03 DE DE59209838T patent/DE59209838D1/de not_active Expired - Fee Related
- 1992-02-03 NZ NZ241505A patent/NZ241505A/en unknown
- 1992-02-03 EP EP92101709A patent/EP0498334B1/de not_active Expired - Lifetime
- 1992-02-03 FI FI920460A patent/FI103117B1/fi active
- 1992-02-03 ES ES92101709T patent/ES2146581T3/es not_active Expired - Lifetime
- 1992-02-03 DK DK92101709T patent/DK0498334T3/da active
- 1992-02-04 CA CA002060622A patent/CA2060622A1/en not_active Abandoned
- 1992-02-04 JP JP4018627A patent/JPH0559041A/ja active Pending
- 1992-02-04 CZ CS92309A patent/CZ283006B6/cs not_active IP Right Cessation
- 1992-02-04 ZA ZA92788A patent/ZA92788B/xx unknown
- 1992-02-04 IE IE036892A patent/IE920368A1/en not_active Application Discontinuation
- 1992-02-04 HU HU9200336A patent/HUT61295A/hu unknown
- 1992-02-04 MX MX9200492A patent/MX9200492A/es unknown
- 1992-02-04 AU AU10724/92A patent/AU650511B2/en not_active Ceased
- 1992-02-04 NO NO920462A patent/NO180446C/no not_active IP Right Cessation
-
1994
- 1994-01-21 US US08/183,786 patent/US5482953A/en not_active Expired - Fee Related
- 1994-10-26 HR HR940840A patent/HRP940840B1/xx not_active IP Right Cessation
-
1995
- 1995-06-05 US US08/465,326 patent/US5614537A/en not_active Expired - Fee Related
-
2000
- 2000-05-31 GR GR20000401228T patent/GR3033536T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU588826B2 (en) | Esters of pyridine-2,4- and 2,5-dicarboxylic acid as medicaments for the inhibition of proline hydroxylase and lysine hydroxylase | |
| MY112413A (en) | Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals | |
| AU635961B2 (en) | Novel peptidase and isomerase inhibitors | |
| NO940789D0 (no) | Quinolinkarboksylsyrederivater, deres fremstilling og anvendelse | |
| TW225532B (el) | ||
| HRP940701A2 (en) | 2,4- and 2,5-substituted pyridine-n-oxydes, process for their preparation and utilization | |
| AR244941A1 (es) | Compuesto, composicion, procedimiento y uso antimicrobiano. | |
| GR3033536T3 (en) | 2,4- and 2,5-bis-(tetrazolyl)pyridines, process for their preparation and their use as medicines. | |
| NO910163D0 (no) | Fremgangsmaate for fremstilling og anvendelse av pyridin-2,4- og 2,5-dikarboksylsyredi-(nitroksyalkyl)amid. | |
| AP9400608A0 (en) | "New nicotinic acid derivative". | |
| NZ225055A (en) | Composition for introducing hypersensitivity to gram-positive bacteria containing exoantigens of the bacteria, or their homologues | |
| HU9200891D0 (en) | Mixed piridine-2,4- and 2,5-docarbonic acid-diamides and medical preparations containing them, and the process for their production |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ML | Lapse due to non-payment of fees |